Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the safety and IOP-lowering efficacy of various low dose travoprost formulations in patients with open-angle glaucoma or ocular hypertension.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Ophthalmic Solutions; Pharmaceutical Solutions; Travoprost

Criteria

Inclusion Criteria:

• Patients 18 years of age or older, either sex or race with open-angle glaucoma or confirmed ocular hypertension

• Other protocol-defined inclusion criteria may apply

Exclusion Criteria:

• Age related

• Other protocol-defined exclusion criteria may apply